Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Enzastaurin
Trade Name
Synonyms LY317615|LY-317615
Drug Descriptions

Enzastaurin (LY317615) is a selective inhibitor PKC-beta, with activity against other PKC isoforms at higher concentrations, which decreases downstream signaling and potentially results in reduced tumor growth (PMID: 16103100, PMID: 17671157, PMID: 22253748, PMID: 32250167).

DrugClasses PKC beta Inhibitor 6
CAS Registry Number 170364-57-5
NCIT ID C77392

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cyclophosphamide + Doxorubicin + Enzastaurin + Prednisone + Rituximab + Vincristine Sulfate Cyclophosphamide Doxorubicin Enzastaurin Prednisone Rituximab Vincristine Sulfate 0 0
Enzastaurin Enzastaurin 0 2
Enzastaurin + Temozolomide Enzastaurin Temozolomide 0 1
Enzastaurin + YK-4-279 Enzastaurin YK-4-279 0 0


Additional content available in CKB BOOST